We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+17.33%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$855M
AUM Growth
-$484M
Cap. Flow
-$652M
Cap. Flow %
-76.28%
Top 10 Hldgs %
18.47%
Holding
215
New
36
Increased
59
Reduced
51
Closed
23

Top Buys

Rank Stock Value
1
WTFC icon
Wintrust Financial
WTFC
+$5.98M
2
BILL icon
BILL Holdings
BILL
+$5.65M
3
BAC icon
Bank of America
BAC
+$5.16M
4
ARHS icon
Arhaus
ARHS
+$5.16M
5
WFRD icon
Weatherford International
WFRD
+$4.72M

Top Sells

Rank Stock Value
1
IMGN
Immunogen Inc
IMGN
+$38.2M
2
ARGX icon
argenx
ARGX
+$36.2M
3
LEGN icon
Legend Biotech
LEGN
+$35.9M
4
KRYS icon
Krystal Biotech
KRYS
+$34M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$32.1M

Sector Composition

Rank Sector Weight
1 Technology 25.82%
2 Industrials 16.86%
3 Healthcare 15.28%
4 Financials 10.16%
5 Consumer Discretionary 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANF icon
76
Abercrombie & Fitch
ANF
$5B
$3.8M 0.44%
+43,096
New +$3.07M
XBI icon
77
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$3.76M 0.44%
+42,094
New +$3.13M
FDX icon
78
FedEx
FDX
$75.4B
$3.71M 0.43%
14,679
+3,079
+27% +$782K
TJX icon
79
TJX Companies
TJX
$178B
$3.65M 0.43%
38,947
+20,843
+115% +$1.87M
ITCI
80
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$3.6M 0.42%
50,244
-285,310
-85% -$16.4M
IMCR icon
81
Immunocore
IMCR
$1.73B
$3.56M 0.42%
52,159
-460,696
-90% -$23.9M
KTB icon
82
Kontoor Brands
KTB
$4.26B
$3.54M 0.41%
+56,645
New +$2.91M
BXSL icon
83
Blackstone Secured Lending
BXSL
$5.72B
$3.53M 0.41%
127,555
-5,596
-4% -$155K
ONON icon
84
On Holding
ONON
$12.5B
$3.51M 0.41%
130,232
+111,829
+608% +$3.05M
SPG icon
85
Simon Property Group
SPG
$72.3B
$3.41M 0.4%
+23,907
New +$2.89M
JPM icon
86
JPMorgan Chase
JPM
$950B
$3.4M 0.4%
19,967
-11,930
-37% -$1.81M
CFLT
87
DELISTED
Confluent
CFLT
$3.39M 0.4%
144,815
-15,967
-10% -$386K
ONTO icon
88
Onto Innovation
ONTO
$15.3B
$3.37M 0.39%
22,029
+269
+1% +$36.2K
VRNA
89
DELISTED
Verona Pharma
VRNA
$3.36M 0.39%
169,126
-993,863
-85% -$14.7M
KLAC icon
90
KLA
KLAC
$259B
$3.31M 0.39%
56,890
+3,000
+6% +$156K
OLLI icon
91
Ollie's Bargain Outlet
OLLI
$4.94B
$3.29M 0.39%
43,384
+1,570
+4% +$118K
MDB icon
92
MongoDB
MDB
$32.1B
$3.26M 0.38%
7,962
+3,710
+87% +$1.41M
AEO icon
93
American Eagle Outfitters
AEO
$3.01B
$3.23M 0.38%
+152,781
New +$2.85M
GLBE icon
94
Global E Online
GLBE
$7.11B
$3.19M 0.37%
80,523
-4,328
-5% -$156K
VRTX icon
95
Vertex Pharmaceuticals
VRTX
$126B
$3.18M 0.37%
7,822
-86,936
-92% -$32.1M
HCP
96
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$3.18M 0.37%
134,498
-22,690
-14% -$492K
KRTX
97
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$3.05M 0.36%
9,644
-82,457
-90% -$16M
EG icon
98
Everest Group
EG
$14.4B
$3.01M 0.35%
8,517
-243
-3% -$94.1K
INTU icon
99
Intuit
INTU
$89B
$3M 0.35%
4,799
+2,820
+142% +$1.56M
SQSP
100
DELISTED
Squarespace, Inc.
SQSP
$2.99M 0.35%
+90,532
New +$2.65M
2 3
4
5 6

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Nicholas Investment Partners held 215 positions worth $855M, down 36% from $1.34B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Nicholas Investment Partners withdrew a net $652M in Q4 2023, closing 23 positions and reducing 51 holdings. Its most notable exit was Establishment Labs, an estimated $30.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 14% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Nicholas Investment Partners opened a new position in Wintrust Financial worth $6.7M.

  • Nicholas Investment Partners's largest Q4 2023 buy was Wintrust Financial: 72,287 shares worth $6.7M.
  • Nicholas Investment Partners added most to BILL Holdings in Q4 2023, an estimated $5.65M increase.
  • Nicholas Investment Partners's biggest Q4 2023 reduction was Immunogen Inc, cutting an estimated $38.2M.
  • Nicholas Investment Partners fully exited Establishment Labs in Q4 2023, selling an estimated $30.5M.
  • Nicholas Investment Partners's ten largest holdings make up 18% of its $855M portfolio in Q4 2023.
  • Nicholas Investment Partners opened 36 new positions and closed 23 in Q4 2023.
  • Nicholas Investment Partners's portfolio value fell 36% quarter-over-quarter to $855M.

Based on Nicholas Investment Partners's 13F filing for Q4 2023, filed 8 Feb 2024.